MYLAN PHARMACEUTICALS INC

Mylan Pharmaceuticals Inc. specializes in the manufacturing and distribution of pharmaceutical preparations, with a demonstrated focus on supplying critical medications to federal healthcare systems. Their technical expertise lies in the production of branded and generic drug formulations, including complex formulations such as carbidopa-levodopa tablets, and in maintaining compliance with stringent federal supply chain requirements for pharmaceuticals. The company excels in managing long-term contract obligations, including option year exercises, cost recovery fee adjustments, and quarterly sales reporting protocols, indicating deep familiarity with federal procurement and financial accountability frameworks for drug procurement programs. The contractor maintains a consistent and primary relationship with the Department of Veterans Affairs, providing pharmaceuticals under Federal Supply Schedule contracts and supporting ongoing supply chain operations through routine contract modifications related to payment remittance, sales reporting, and regulatory compliance. Their work with the Department of Defense and DLA Troop Support further confirms their role in sustaining military and veteran pharmaceutical needs, particularly for high-volume, mission-critical medications. Their primary NAICS code, 325412, reflects active involvement in pharmaceutical preparation manufacturing, encompassing the formulation, packaging, and distribution of oral solids, injectables, and other dosage forms under cGMP standards. This positions them as a reliable supplier within the government’s pharmaceutical supply network, focused on therapeutic areas including neurology and hematology. Mylan Pharmaceuticals Inc. operates as a 2L entity based in Morgantown, West Virginia. While no government certifications are listed, their sustained contract activity with federal agencies underscores their established credibility in meeting the quality, traceability, and regulatory demands of public sector pharmaceutical procurement. Their geographic presence and operational focus align with national defense and veteran healthcare supply chain priorities.